An imported case of Bundibugyo virus disease in Kenya raises questions about airport screening, clinical recognition, and potential exposures, highlighting the importance of coordinated contact tracing and hospital infection prevention readiness.
|Articles|November 5, 2013
AGA Publishes Clinical Decision Tool to Help GIs Manage HCV Patients
Advertisement
The American Gastroenterological Association (AGA) Clinical Decision Tool for the Screening and Evaluation of Hepatitis C (HCV) will help gastroenterologists in the early management of HCV-positive patients, according to a new paper in Gastroenterology, the journal of the American Gastroenterological Association. Chronic HCV has a significant impact on the adult population and is a disease for which much progress has been made in its treatment.
"The publication of this clinical decision support tool marks a milestone for the AGA," according to John I. Allen, MD, MPH, AGAF, chair of the Hepatitis C Screening and Evaluation Task Force and president-elect of the AGA Institute. "This tool is the first in a series of care pathways that the AGA is developing as part of the Roadmap to the Future of GI, which is designed to provide gastroenterologists with the tools they need to thrive in an accountable care world."
The recommendations for population based screening by the Centers for Disease Control and Prevention (CDC)Â and the U.S. Preventive Services Task Force (all people born between 1945 and 1965) were created in an effort to identify the 2.7 to 3.9 million Americans living with chronic HCV infection. The identification of this population and the subsequent management of the disease will overwhelm the current capacity of hepatologists. It is vital, therefore, that general gastroenterologists engage in the management of HCV patients.
The HCV Clinical Decision Tool is unique in that each decision point was evaluated and graded for its strength of evidence and strength of recommendation. It was designed to aid gastroenterologists in the early management of HCV-positive patients through an evidence-based, cost effective initial evaluation of HCV-positive patients.
"As the U.S. moves into a healthcare delivery world constrained by financial pressures and characterized by accountable care, risk contracting for population management and reimbursements tied to outcomes, the tools created by the AGA will aid gastroenterologists to redesign their practice to meet these challenges," says Allen.
Source: American Gastroenterological Association
Advertisement
Related to this article
Florida’s dengue outbreak highlights the importance of recognizing symptoms, identifying warning signs, and preventing mosquito bites. Ubong Johnson, MD, explains local transmission, diagnostic testing, treatment, and practical prevention measures.
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Advertisement
Advertisement